Weighted Average Number of Shares Outstanding, Diluted of Bone Biologics Corp from Q2 2016 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bone Biologics Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2016 to Q3 2025.
- Bone Biologics Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 1.8M shares, a 514% increase year-over-year.
- Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1.52M shares, a 477% increase from 2023.
- Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 263K shares, a 452% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)